Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007199 | SCV002232901 | pathogenic | Familial adenomatous polyposis 2 | 2022-05-21 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu134Glyfs*118) in the MUTYH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). |
Center for Genomic Medicine, |
RCV002268588 | SCV002552519 | likely pathogenic | not provided | 2023-08-15 | criteria provided, single submitter | clinical testing |